Ontx stock
Web11 de abr. de 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Onconova Therapeutics stock is Buy based on the current 1 buy rating for ONTX. The average twelve-month price prediction for Onconova Therapeutics is $11.00 with a high price target of $11.00 and a low price target of $11.00. Web31 de mar. de 2024 · Onconova Therapeutics, Inc. Common Stock (ONTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Skip to …
Ontx stock
Did you know?
WebONTX has a Quality Grade of D, ranking ahead of 8.68% of graded US stocks. ONTX's asset turnover comes in at 0.007 -- ranking 403rd of 682 Pharmaceutical Products stocks. IDRA, MYMD, and CAPR are the stocks whose asset turnover ratios are most correlated with ONTX. The table below shows ONTX's key quality metrics over time. Web18 de mar. de 2024 · Onconova Therapeutics stock was originally listed at a price of $44,729.96 in Jul 25, 2013. If you had invested in Onconova Therapeutics stock at …
Web10 de abr. de 2024 · Onconova Therapeutics, Inc. (ONTX) Reports Q2 Loss, Lags Revenue Estimates. Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue … Web6 de abr. de 2024 · View real-time ONTX stock price and news, along with industry-best analysis. Complete Onconova Therapeutics Inc. stock information by Barron's. Search …
Web12 de ago. de 2024 · Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.60 per share a year ago. WebONTX Complete Onconova Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
WebDiscover historical prices for ONTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Onconova Therapeutics, Inc. stock was issued.
Web8 de abr. de 2024 · Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a … incorta infosysWebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … incorta insightsWeb28 de mar. de 2024 · The Onconova Therapeutics stock price fell by -0.90% on the last day (Tuesday, 28th Mar 2024) from $0.715 to $0.709. During the last trading day the stock fluctuated 3.03% from a day low at $0.709 to a day high of $0.730. The price has risen in 6 of the last 10 days but is still down by -2.26% for this period. incorta function case contains booleanWebOnconova Therapeutics, Inc. (ONTX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 0.7000 -0.0100 (-1.41%) At close: 04:00PM EDT. 0.6900 … incorruptible st. bernadetteWebFind the latest ON24, Inc. (ONTF) stock quote, history, news and other vital information to help you with your stock trading and investing. incorta internshipWeb20 de mai. de 2024 · Onconova’s common stock will continue to trade on the Nasdaq Capital Market under the trading symbol “ONTX.” The new CUSIP number for the common stock following the reverse stock split is ... incorta enterprise account manager salaryWeb6 de abr. de 2024 · Complete Onconova Therapeutics Inc. stock information by Barron's. View real-time ONTX stock price and news, along with industry-best analysis. incorta add avg of rows